New YorkA 6922025-2026 Regular SessionHouseWALLET

Makes technical changes to certain provisions requiring epinephrine auto-injector devises to be made available in places of public assembly

Sponsored By: Linda Rosenthal (Democratic)

Became Law

HEALTHRULES

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

More time to add epinephrine auto-injectors at venues

The law delays the start of the 2024 epinephrine auto-injector rule for places of public assembly. The requirement starts nine months after the 2024 chapter became law. Agencies can write and finish rules before that date. This act takes effect now, but its technical fixes start on the same date as the 2024 chapter. This gives venues more time to train staff and buy devices.

Clearer rules for auto-injectors at venues

The law renumbers the epinephrine auto-injector rule so it is now subdivision 5-e. It also fixes a citation in section 3000-c to point to 5-e. It clarifies that eligible people or entities are not required to get, store, or use an auto-injector unless the public assembly rule in 5-e requires it. These technical updates take effect on the same date as the 2024 chapter.

Sponsors & Cosponsors

Sponsor

Linda Rosenthal
Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

All Roll Calls

Yes: 63 • No: 0

House vote • 2/3/2025

FLOOR Vote